5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Protective effects of the Francisella tularensis Δ pdpC mutant against its virulent parental strain SCHU P9 in Cynomolgus macaques

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Tularemia is a severe infectious zoonotic disease caused by Francisella tularensis. Although F. tularensis is considered to be a potential biological weapon due to its high infectivity and mortality rate, no vaccine has been currently licensed. Recently, we reported that F. tularensis SCHU P9 derived Δ pdpC strain lacking the pathogenicity determinant protein C gene conferred stable and good protection in a mouse lethal model. In this study, the protective effect of Δ pdpC was evaluated using a monkey lethal model. Two cynomolgus macaques ( Macaca fascicularis) intratracheally challenged with the virulent strain SCHU P9 were euthanized on 7 and 11 days post-challenge after the development of severe clinical signs. The bacterial replication in alveolar macrophages and type II epithelial cells in the lungs would cause severe pneumonia accompanied by necrosis. Conversely, two animals subcutaneously immunized with Δ pdpC survived 3 weeks after SCHU P9 challenge. Though one of the two animals developed mild symptoms of tularemia, bacterial replication was limited in the respiratory organs, which may be due to a high level of humoral and cellular immune responses against F. tularensis. These results suggest that the Δ pdpC mutant would be a safe and promising candidate as a live attenuated tularemia vaccine.

          Related collections

          Most cited references58

          • Record: found
          • Abstract: found
          • Article: not found

          Tularaemia: bioterrorism defence renews interest in Francisella tularensis.

          Francisella tularensis is a highly infectious aerosolizable intracellular pathogen that is capable of causing a debilitating or fatal disease with doses as low as 25 colony-forming units. There is no licensed vaccine available. Since the 1950s there has been concern that F. tularensis could be used as a biological threat agent, and it has received renewed attention recently owing to concerns about bioterrorism. The International Conference on Tularaemia in 2003 attracted more than 200 delegates, twice the number of participants as previous meetings. This is a reflection of the increased funding of research on this pathogen, particularly in the United States.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Tularemia

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Tularemia vaccine study. II. Respiratory challenge.

                Bookmark

                Author and article information

                Contributors
                auda@nih.go.jp
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                24 June 2019
                24 June 2019
                2019
                : 9
                : 9193
                Affiliations
                [1 ]ISNI 0000 0001 2151 536X, GRID grid.26999.3d, Laboratory of Veterinary Public Health, Department of Veterinary Medical Science, Graduate School of Agricultural and Life Sciences, , The University of Tokyo, ; Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657 Japan
                [2 ]ISNI 0000 0001 2220 1880, GRID grid.410795.e, Department of Veterinary Science, , National Institute of Infectious Diseases, ; Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640 Japan
                [3 ]ISNI 0000 0001 2220 1880, GRID grid.410795.e, Division of Experimental Animal Research, , National Institute of Infectious Disease, Gakuen 4-7-1, ; Musashimurayama-shi, Tokyo 208-0011 Japan
                [4 ]ISNI 0000 0001 2220 1880, GRID grid.410795.e, Department of Pathology, , National Institute of Infectious Diseases, ; Gakuen 4-7-1, Musashimurayama-shi, Tokyo 208-0011 Japan
                [5 ]ISNI 0000 0004 0370 4927, GRID grid.256342.4, Major Track of Applied Veterinary Science, Doctoral Course of the United Graduate School of Veterinary Sciences, , Gifu University, ; Yanagido 1-1, Gifu-shi, Gifu 501-1193 Japan
                [6 ]ISNI 0000 0001 2149 8846, GRID grid.260969.2, Department of Integrated Science in Physics and Biology, College of Humanities and Sciences, , Nihon University, ; Sakurajosui 3-25-40, Setagaya-ku, Tokyo 156-8550 Japan
                Article
                45412
                10.1038/s41598-019-45412-8
                6591246
                31235714
                f0f9bbdc-14ab-42bc-938e-7e009681deb2
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 25 October 2018
                : 6 June 2019
                Funding
                Funded by: FundRef https://doi.org/10.13039/100009619, Japan Agency for Medical Research and Development (AMED);
                Award ID: 19fk0108097j0601
                Award ID: 18fk0108017j0103
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100001691, MEXT | Japan Society for the Promotion of Science (JSPS);
                Award ID: 16K09955
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2019

                Uncategorized
                bacterial infection,live attenuated vaccines
                Uncategorized
                bacterial infection, live attenuated vaccines

                Comments

                Comment on this article